Defensins in innate immunity

Current Opinion in Hematology

Volumn 21, Issue 1, 2014, Pages 37-42

  Zhao, Le ^a   Lu, Wuyuan ^b  

^a MEDICAL SCHOOL OF XI AN JIAOTONG UNIVERSITY   (China)

^b INSTITUTE OF HUMAN VIROLOGY   (United States)

Author keywords

antimicrobial peptides; defensins; innate immunity

Indexed keywords

ALPHA DEFENSIN; DEFENSIN; THETA DEFENSIN; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; BACTERIAL MEMBRANE; CELLULAR IMMUNITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HYDROPHOBICITY; INNATE IMMUNITY; INTESTINE EPITHELIUM; MEMBRANE DAMAGE; MUCOSAL IMMUNITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN QUATERNARY STRUCTURE; REVIEW; SALMONELLA TYPHIMURIUM; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PYOGENES;

ALPHA-DEFENSINS; ANTI-INFECTIVE AGENTS; BACTERIAL INFECTIONS; DEFENSINS; HIV INFECTIONS; HIV-1; HUMANS; IMMUNITY, INNATE;

EID: 84890565133     PISSN: 10656251     EISSN: 15317048     Source Type: Journal    
DOI: 10.1097/MOH.0000000000000005     Document Type: Review

References (58)

1. & Lehrer RI, Lu W. alpha-Defensins in human innate immunity. Immunol Rev 2012; 245 84-112. This is a comprehensive review of alpha-defensins by Robert Lehrer who discovered this class of antimicrobial peptides first from the rabbit and later from humans, and who coined the term 'defensin'.
2. Semple F, Dorin Jr. Beta-defensins: Multifunctional modulators of infection, inflammation and more J Innate Immun 2012; 4:337-348.
3. Tollner TL, Bevins CL, Cherr GN. Multifunctional glycoprotein DEFB126: A curious story of defensin-clad spermatozoa. Nat Rev Urol 2012; 9:365-375.
4. Weinberg A, Jin G, Sieg S, McCormick TS. The yin and yang of human Betadefensins in health and disease. Front Immunol 2012; 3:294.
5. Lehrer RI, Cole AM, Selsted ME. Theta-defensins: Cyclic peptides with endless potential. J Biol Chem 2012; 287:27014-27019. This is a concise review by the three most authoritative theta-defensin researchers.
6. Yount NY, Yeaman MR. Peptide antimicrobials: Cell wall as a bacterial target. Ann N Y Acad Sci 2013; 1277:127-138.
7. Oeemig JS, Lynggaard C, Knudsen DH, et al. Eurocin, a new fungal defensin: Structure, lipid binding, and its mode of action. J Biol Chem 2012; 287:42361-42372.
8. Vega LA, Caparon MG. Cationic antimicrobial peptides disrupt the Streptococcus pyogenes ExPortal. Mol Microbiol 2012; 85:1119-1132. This study describes a new mechanism of action of HNP1 that inhibits S. pyogenes infection and survival by blocking ExPortal-mediated secretion of certain bacterial toxins.
9. Chu H, Pazgier M, Jung G, et al. Human alpha-defensin 6 promotes mucosal innate immunity through self-assembled peptide nanonets. Science 2012; 337:477-481. A paradigm-shifting discovery of how the human enteric alpha-defensin 6, which lacks bactericidal activity in vitro, protects against bacterial invasion of the intestinal epithelium by entrapping enteric pathogens.
10. Clevers HC, Bevins CL. Paneth cells: Maestros of the small intestinal crypts. Annu Rev Physiol 2013; 75:289-311. This is a timely review on the human enteric alpha-defensins 5 and 6 by Charles Bevins, who originally discovered them from Paneth cells, and the role of Paneth cells in intestinal homeostasis and innate immunity.
11. Raetz M, Hwang SH, Wilhelm CL, et al. Parasite-induced TH1 cells and intestinal dysbiosis cooperate in IFN-gamma-dependent elimination of Paneth cells. Nat Immunol 2013; 14:136-142. This interesting study describes how protozoan parasitic infection kills Paneth cells and blocks antimicrobial responses at the intestinal mucosal surface.
12. Eriguchi Y, Takashima S, Oka H, et al. Graft-versus-host disease disrupts intestinal microbial ecology by inhibiting Paneth cell production of alphadefensins. Blood 2012; 120:223-231.
13. Gersemann M, Wehkamp J, Stange EF. Innate immune dysfunction in inflammatory bowel disease. J Intern Med 2012; 271:421-428.
14. Koslowski MJ, Teltschik Z, Beisner J, et al. Association of a functional variant in the Wnt co-receptor LRP6 with early onset ileal Crohn's disease. PLoS Genet 2012; 8:e1002523.
15. Klotman ME, Chang TL. Defensins in innate antiviral immunity. Nat Rev Immunol 2006; 6:447-456.
16. Demirkhanyan LH, Marin M, Padilla-Parra S, et al. Multifaceted mechanisms of HIV-1 entry inhibition by human alpha-defensin. J Biol Chem 2012; 287: 28821-28838. This is a technically superb piece of work that painstakingly investigates the molecular events leading to the inhibition of HIV-1 entry and fusion by HNP1.
17. Demirkhanyan L, Marin M, Lu W, Melikyan GB. Sub-inhibitory concentrations of human alpha-defensin potentiate neutralizing antibodies against HIV-1 gp41 prehairpin intermediates in the presence of serum. PLoS Pathog 2013; 9:e1003431.
18. Klotman ME, Rapista A, Teleshova N, et al. Neisseria gonorrhoeae-induced human defensins 5 and 6 increase HIV infectivity: Role in enhanced transmission. J Immunol 2008; 180:6176-6185.
19. Rapista A, Ding J, Benito B, et al. Human defensins 5 and 6 enhance HIV-1 infectivity through promoting HIV attachment. Retrovirology 2011; 8:45.
20. Jarvis GA, Chang TL. Modulation of HIV transmission by Neisseria gonorrhoeae: Molecular and immunological aspects. Curr HIV Res 2012; 10:211-217.
21. Furci L, Tolazzi M, Sironi F, et al. Inhibition of HIV-1 infection by human alphadefensin-5, a natural antimicrobial peptide expressed in the genital and intestinal mucosae. PLoS One 2012; 7:e45208.
22. Lu W, de Leeuw E. Pro-inflammatory and pro-apoptotic properties of human defensin Biochem Biophys Res Commun 2013; 436:557-562.
23. Ding J, Tasker C, Valere K, et al. Anti-HIV activity of human defensin 5 in primary CD4 T cells under serum-deprived conditions is a consequence of defensin-mediated toxicity. PLoS One 2013; 8:e76038.
24. Zhao L, Ericksen B, Wu X, et al. Invariant Gly residue is important for alphadefensin folding, dimerization, and function: A case study of the human neutrophil alpha-defensin HNP1. J Biol Chem 2012; 287:18900-18912.
25. Wommack AJ, Robson SA, Wanniarachchi YA, et al. NMR solution structure and condition-dependent oligomerization of the antimicrobial peptide human defensin Biochemistry 2012 51:9624-9637.
26. Pazgier M, Wei G, Ericksen B, et al. Sometimes it takes two to tango: Contributions of dimerization to functions of human alpha-defensin HNP1 peptide. J Biol Chem 2012; 287:8944-8953. This study elegantly demonstrates for the first time functional importance of HNP1 dimerization.
27. Wei G, Pazgier M, de Leeuw E, et al. Trp-26 imparts functional versatility to human alpha-defensin HNP1. J Biol Chem 2010; 285:16275-16285.
28. Rajabi M, Ericksen B, Wu X, et al. Functional determinants of human enteric alpha-defensin HD5: Crucial role for hydrophobicity at dimer interface. J Biol Chem 2012; 287:21615-21627.
29. Buck CB, Day PM, Thompson CD, et al. Human alpha-defensins block papillomavirus infection. Proc Natl Acad Sci U S A 2006; 103:1516-1521.
30. Flatt JW, Kim R, Smith JG, et al. An intrinsically disordered region of the adenovirus capsid is implicated in neutralization by human alpha defensin PLoS One 2013; 8:e61571.
31. Snijder J, Reddy VS, May ER, et al. Integrin and defensin modulate the mechanical properties of adenovirus. J Virol 2013; 87:2756-2766.
32. Gounder AP, Wiens ME, Wilson SS, et al. Critical determinants of human alpha-defensin 5 activity against nonenveloped viruses. J Biol Chem 2012; 287:24554-24562. This interesting study describes a systematic mutational study of HD5 with respect to its capsid-binding and antiviral activity against human adenovirus.
33. Schmidt NW, Tai KP, Kamdar K, et al. Arginine in alpha-defensins: Differential effects on bactericidal activity correspond to geometry of membrane curvature generation and peptide-lipid phase behavior. J Biol Chem 2012; 287:21866-21872.
34. Wang A, Chen F, Wang Y, et al. Enhancement of antiviral activity of human alpha-defensin 5 against herpes simplex virus 2 by arginine mutagenesis at adaptive evolution sites. J Virol 2013; 87:2835-2845.
35. Conibear AC, Rosengren KJ, Harvey PJ, Craik DJ. Structural characterization of the cyclic cystine ladder motif of theta-defensins. Biochemistry 2012; 51:9718-9726.
36. Conibear AC, Rosengren KJ, Daly NL, et al. The cyclic cystine ladder in thetadefensins is important for structure and stability, but not antibacterial activity. J Biol Chem 2013; 288:10830-10840.
37. Liu PT, Wheelwright M, Teles R, et al. MicroRNA-21 targets the vitamin Ddependent antimicrobial pathway in leprosy. Nat Med 2012; 18:267-273. This study demonstrates that induction of vitamin D-dependent endogenous antimicrobial responses via gene regulation can be a potential therapeutic strategy for the treatment of infectious diseases where cellular immune responses are dysregulated.
38. Teles RM, Graeber TG, Krutzik SR, et al. Type I interferon suppresses type II interferon-triggered human antimycobacterial responses. Science 2013; 339:1448-1453.
39. Tang YQ, Yuan J, Osapay G, et al. A cyclic antimicrobial peptide produced in primate leukocytes by the ligation of two truncated alpha-defensins. Science 1999; 286:498-502.
40. Doss M, Ruchala P, Tecle T, et al. Hapivirins and diprovirins: Novel thetadefensin analogs with potent activity against influenza A virus. J Immunol 2012; 188:2759-2768.
41. Rothan HA, Han HC, Ramasamy TS, et al. Inhibition of dengue NS2B-NS3 protease and viral replication in Vero cells by recombinant retrocyclin-1. BMC Infect Dis 2012; 12:314.
42. Schaal JB, Tran D, Tran P, et al. Rhesus macaque theta defensins suppress inflammatory cytokines and enhance survival in mouse models of bacteremic sepsis. PLoS One 2012; 7:e51337. This is an interesting study that demonstrates therapeutic potential of thetadefensins as a novel class of anti-inflammatory agents for the treatment of bacteremic sepsis and possibly autoimmune diseases.
43. Eade CR, Wood MP, Cole AM. Mechanisms and modifications of naturally occurring host defense peptides for anti-HIV microbicide development. Curr HIV Res 2012; 10:61-72.
44. Gupta P, Lackman-Smith C, Snyder B, et al. Antiviral activity of retrocyclin RC-101, a candidate microbicide against cell-associated HIV-1. AIDS Res Hum Retroviruses 2013; 29:391-396.
45. Wood MP, Cole AL, Ruchala P, et al. A compensatory mutation provides resistance to disparate HIV fusion inhibitor peptides and enhances membrane fusion. PLoS One 2013; 8:e55478.
46. Eade CR, Cole AL, Diaz C, et al. The anti-HIV microbicide candidate RC-101 inhibits pathogenic vaginal bacteria without harming endogenous flora or mucosa. Am J Reprod Immunol 2013; 69:150-158.
47. Venkataraman N, Cole AL, Ruchala P, et al. Reawakening retrocyclins: Ancestral human defensins active against HIV-1. PLoS Biol 2009; 7: E95.
48. Craik DJ, Allewell NM. Thematic minireview series on circular proteins. J Biol Chem 2012; 287:26999-27000. This is a concise review by an authority on many important aspects of cyclic peptides and circular proteins.
49. Dawson PE, Kent SB. Synthesis of native proteins by chemical ligation. Annu Rev Biochem 2000; 69:923-960.
50. Dawson PE, Muir TW, Clark-Lewis I, Kent SB. Synthesis of proteins by native chemical ligation. Science 1994; 266:776-779.
51. Aboye TL, Li Y, Majumder S, et al. Efficient one-pot cyclization/folding of Rhesus theta-defensin-1 (RTD-1). Bioorg Med Chem Lett 2012; 22:2823-2826. This study describes an efficient chemical approach to the production of synthetic theta-defensins.
52. Muir TW. Semisynthesis of proteins by expressed protein ligation. Annu Rev Biochem 2003; 72:249-289.
53. Gould A, Li Y, Majumder S, et al. Recombinant production of rhesus thetadefensin-1 (RTD-1) using a bacterial expression system. Mol Biosyst 2012; 8:1359-1365. This study describes an efficient bacterial expression system for the production of recombinant theta-defensins.
54. Rapireddy S, Nhon L, Meehan RE, et al. RTD-1mimic containing gammaPNA scaffold exhibits broad-spectrum antibacterial activities. J Am Chem Soc 2012; 134:4041-4044.
55. Glenthoj A, Glenthoj AJ, Borregaard N. ProHNPs are the principal alphadefensins of human plasma. Eur J Clin Invest 2013; 43:836-843.
56. Tongaonkar P, Golji AE, Tran P, et al. High fidelity processing and activation of the human alpha-defensin HNP1 precursor by neutrophil elastase and proteinase PLoS One 2012; 7:e32469.
57. Ouellette AJ. Paneth cell alpha-defensins in enteric innate immunity. Cell Mol Life Sci 2011; 68:2215-2229.
58. Selsted ME, Ouellette AJ. Mammalian defensins in the antimicrobial immune response. Nature Immunol 2005; 6:551-557.